CTI BioPharma
CTIC
#5200
Rank
โ‚ฌ1.13 B
Marketcap
8,63ย โ‚ฌ
Share price
0.00%
Change (1 day)
34.82%
Change (1 year)

Revenue for CTI BioPharma (CTIC)

Revenue in 2023 (TTM): โ‚ฌ72.12 Million

According to CTI BioPharma 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ71.95 Million. In 2022 the company made a revenue of โ‚ฌ50.29 Million an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CTI BioPharma from 1997 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚ฌ72.12 M43.42%
2022 โ‚ฌ50.29 M
2021 N/A
2020 N/A-100%
2019 โ‚ฌ2.98 M-86.82%
2018 โ‚ฌ22.65 M8.12%
2017 โ‚ฌ20.95 M-61.6%
2016 โ‚ฌ54.57 M270.27%
2015 โ‚ฌ14.73 M-70.16%
2014 โ‚ฌ49.39 M96.72%
2013 โ‚ฌ25.11 M
2012 N/A
2011 N/A-100%
2010 โ‚ฌ0.23 M329.5%
2009 โ‚ฌ0.05 M-99.32%
2008 โ‚ฌ8.17 M9301.53%
2007 โ‚ฌ0.08 M43.46%
2006 โ‚ฌ0.06 M-99.55%
2005 โ‚ฌ13.58 M-37.73%
2004 โ‚ฌ21.81 M10.91%
2003 โ‚ฌ19.67 M21.7%
2002 โ‚ฌ16.16 M128.9%
2001 โ‚ฌ7.06 M1224.97%
2000 โ‚ฌ0.53 M78.75%
1999 โ‚ฌ0.29 M-97.32%
1998 โ‚ฌ11.12 M11.86%
1997 โ‚ฌ9.94 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ30.89 B 42,838.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.04 B 62,504.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.87 B 5,279.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.24 B 19,693.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.80 B 53,831.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.46 B 21,399.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ47.42 B 65,810.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland